Harish Shantharam - 26 Jan 2026 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Financial Officer
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
26 Jan 2026
Net transactions value
$0
Form type
4
Filing time
28 Jan 2026, 16:30:12 UTC
Previous filing
16 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shantharam Harish Chief Financial Officer C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Shelly Pinto, by power of attorney 28 Jan 2026 0001976391

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock option (right to buy) Award $0 +303,000 $0.000000 303,000 26 Jan 2026 Common Stock 303,000 $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.